300267 尔康制药
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资71,733-0.01%71,740120,229138,968146,158
投资性房地产77,281-1.03%78,08381,28885,26388,656
固定资产2,358,643-1.10%2,384,9732,577,8322,681,7091,983,721
在建工程180,2783.27%174,575220,89052,917506,179
无形资产359,177-1.20%363,556378,034406,136431,447
商誉2,0030.00%2,0032,00310,00810,008
其他非流动资产398,498-2.26%407,723367,778389,666319,445
3,447,614-1.01%3,482,6533,748,0553,764,6683,485,614

流动资产
货币资金686,062-1.79%698,538744,350764,669761,564
应收账款140,85636.51%103,182109,154133,693186,496
存货670,91511.67%600,779691,603821,345714,772
其他流动资产178,882-43.14%314,583185,907371,497283,533
1,676,715-2.35%1,717,0821,731,0142,091,2041,946,365

流动负债
短期借款401,262-17.81%488,198341,889396,641246,000
应付票据0--0000
应付帐款121,5025.97%114,656122,299198,705137,871
其他流动负债96,057-6.27%102,487139,113130,087115,056
618,820-12.27%705,342603,301725,433498,926
流动资产净值1,057,8954.56%1,011,7401,127,7131,365,7711,447,439
资产总额减流动负债4,505,5100.25%4,494,3924,875,7685,130,4394,933,053

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债90,750-1.57%92,19965,75479,13559,351
90,750-1.57%92,19965,75479,13559,351

总权益
    实收股本2,062,6050.00%2,062,6052,062,6052,062,6052,062,605
    储备项目2,401,6390.71%2,384,8212,773,4412,988,4262,788,607
股东权益4,464,2440.38%4,447,4264,836,0465,051,0314,851,211
非控股权益(49,485)9.40%(45,232)(26,032)27322,490